Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | NQO2 | P16083 | 6/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | GLA | P06280 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | ACHE | P22303 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | POLB | P06746 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.61 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenazine SCHEMBL9049 | 1.00 | MAPT (1.00) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL27643128 | 1.00 | MAPT (1.00) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL11126178 | 0.96 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL20475326 | 0.96 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL6329249 | 0.96 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL3119916 | 0.96 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL20475337 | 0.96 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL22345160 | 0.96 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL10866237 | 0.96 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL17187692 | 0.96 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3762382-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2026-04-29 | — | — | EP | claimed |
| EP-3262055-B1 | WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS | SONY GROUP CORP (JP) | 2026-04-22 | — | — | EP | claimed |
| EP-4363396-B1 | PROCESS FOR PRODUCING ANILINE | BASF SE (DE) | 2026-04-15 | — | — | EP | claimed |
| EP-4055088-B1 | COMPOSITION AND METHOD FOR MANUFACTURING RESINS | CAMBIUM BIOMATERIALS INC (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4455168-B1 | VISIBLE LIGHT CURABLE COMPOSITION AND VISIBLE LIGHT CURABLE COMPOSITION POLYMERIZATION METHOD | CHT TURKEY KIMYA SANAYI VE TICARET A S (TR) | 2025-12-24 | — | — | EP | claimed |
| EP-4137818-B1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY GROUP CORP (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4384016-B1 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | BAYER AG (DE) | 2025-09-03 | — | — | EP | claimed |
| EP-3440136-B1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | SONY GROUP CORP (JP) | 2025-07-23 | — | — | EP | claimed |
| EP-3923064-B1 | ELECTROCHROMIC SOLUTION | ESSILOR INT (FR) | 2025-05-21 | — | — | EP | claimed |
| EP-3419989-B1 | REDOX LABELED OLIGONUCLEOTIDE PROBES AND THEIR USE | ABBOTT DIAGNOSTICS SCARBOROUGH INC (US) | 2025-03-19 | — | — | EP | claimed |
| WO-2023208261-A1 | REDOX FLOW CELL | Schaeffler Technologies AG & Co. KG (DE) | 2023-11-02 | — | — | WO | claimed |
| EP-3770163-B1 | COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-05-10 | — | — | EP | claimed |
| EP-3674381-B1 | ORGANIC OPTICAL MATERIAL | JAPAN SCIENCE & TECH AGENCY (JP) | 2023-05-10 | — | — | EP | claimed |
| EP-4017953-B1 | DETERGENT SOLID COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2023-04-12 | — | — | EP | claimed |
| EP-3839007-B1 | ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT | CANON KK (JP) | 2022-12-07 | — | — | EP | claimed |
| US-20220336811-A1 | CATHODE ACTIVE MATERIAL FOR SECONDARY BATTERY COMPRISING CHARGE TRANSFER COMPLEX AND METHOD FOR MANUFACTURING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2022-10-20 | — | — | US | claimed |
| EP-3769085-B1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY GROUP CORP (JP) | 2022-08-24 | — | — | EP | claimed |
| EP-3663288-B1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO (JP) | 2022-06-08 | — | — | EP | claimed |
| EP-3778578-B1 | IMMUNOPROTEASOME INHIBITOR ANALOGS FOR TREATING INFLAMMATORY DISEASES | UNIV CALIFORNIA (US) | 2022-05-04 | — | — | EP | claimed |
| EP-3439077-B1 | LITHIUM-IODINE ELECTROCHEMICAL CELLS EXHIBITING LOW DISCHARGE IMPEDANCE | GREATBATCH LTD (US) | 2022-02-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220336811-A1 | CATHODE ACTIVE MATERIAL FOR SECONDARY BATTERY COMPRISING CHARGE TRANSFER COMPLEX AND METHOD FOR MANUFACTURING SAME | SCO2, TRMT1, ETFB | MAPT 1777/4885NQO2 955/4885ALDH1A1 3004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.